Specification of Drug Substances and Products: Development and Validation of Analytical Methods

0 avg rating
( 0 ratings by Goodreads )
 
9780080983509: Specification of Drug Substances and Products: Development and Validation of Analytical Methods
View all copies of this ISBN edition:
 
 

Specification of Drug Substances and Products: Development and Validation of Analytical Methods is a comprehensive and critical analysis of the requirements and approaches to setting specifications for new pharmaceutical products, with an emphasis on phase-appropriate development and validation of analytical methods. This book is intended as more than a review of new regional guidelines, existing regulatory guidance, and industry practices. It provides a hands-on guide to understanding and applying these in practice. The authors discuss critical issues, novel approaches, and future directions while also providing insight into how International Guidelines were developed and the rationale behind them.

  • Guide to industry best practices of analytical methodologies used in the specification of new drug substances and products (e.g. DOE, QbD)
  • Critical assessment of the application of ICH guidelines on method validation and specification setting, written by experts involved in the development and application of the guidelines to aid understanding of requirements and what is expected by regulatory authorities
  • Direct applicability to the day-to-day activities in drug development and the potential to increase productivity

"synopsis" may belong to another edition of this title.

About the Author:

President of Riley and Rabel Consulting Services. Former Vice President of Analytical R&D at DuPont Pharmaceutical Company, and Vice President of ChemPharm at ALZA (a division of Johnson and Johnson) as well as a member of the ICH Expert Working Group on Impurities.

Director of Business Development at Acceleration Laboratory Services, Incorporated. He has previously held scientific and senior management positions at The Upjohn Company, Marion Laboratories, Marion Merrell Dow, Hoechst Marion Roussel, Quintiles, Eli Lilly, Beckloff Associates, and PPD. He currently serves on a Small Molecule USP Expert Committee.

Assistant Professor of Chemistry in the Department of Natural Sciences at Northwest Missouri State University, as well as Vice-President of Riley and Rabel Consulting Services. She has previously held Principal Scientist positions at DuPont Pharmaceutical Company and ALZA (a division of Johnson and Johnson), and served as Director of Small Molecule Pharmaceutics at Amgen.

Review:

"...a valuable addition to a pharmaceutical scientists’ library....relevant and of interest to various “stake-holders in the drug development arena, including chemists, analysts, and programme managers. I can recommend it."--Organic Process Research & Development Journal, Sep-14

"Its main role is to explain how to meet the most recent International Conference on Harmonization guidelines for drug development. The book is organized to offer a critical and comprehensive account of the approaches used to identify the key determinants of quality production that affect the safety, effectiveness, and marketability of a drug."--ProtoView.com, April 2014

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 119.95
US$ 95.73

Convert currency

Shipping: FREE
From United Kingdom to U.S.A.

Destination, rates & speeds

Add to Basket

Other Popular Editions of the Same Title

9780081013137: Specification of Drug Substances and Products: Development and Validation of Analytical Methods

Featured Edition

ISBN 10:  0081013132 ISBN 13:  9780081013137
Publisher: Elsevier, 2018
Softcover

Top Search Results from the AbeBooks Marketplace

1.

Unknown AEHLERT
Published by Elsevier Health Sciences, United Kingdom (2013)
ISBN 10: 0080983502 ISBN 13: 9780080983509
New Hardcover Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Elsevier Health Sciences, United Kingdom, 2013. Hardback. Condition: New. 2nd edition. Language: English. Brand new Book. Specification of Drug Substances and Products: Development and Validation of Analytical Methods is a comprehensive and critical analysis of the requirements and approaches to setting specifications for new pharmaceutical products, with an emphasis on phase-appropriate development and validation of analytical methods. This book is intended as more than a review of new regional guidelines, existing regulatory guidance, and industry practices. It provides a hands-on guide to understanding and applying these in practice. The authors discuss critical issues, novel approaches, and future directions while also providing insight into how International Guidelines were developed and the rationale behind them. Seller Inventory # EOD9780080983509

More information about this seller | Contact this seller

Buy New
US$ 95.73
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Riley, Christopher M.;rosanske, Thomas W.;rabel Riley, Shelley R.
ISBN 10: 0080983502 ISBN 13: 9780080983509
New Quantity Available: 5
Seller:
GreatBookPrices
(Columbia, MD, U.S.A.)
Rating
[?]

Book Description Condition: New. Seller Inventory # 19607724-n

More information about this seller | Contact this seller

Buy New
US$ 93.09
Convert currency

Add to Basket

Shipping: US$ 2.64
Within U.S.A.
Destination, rates & speeds

3.

Unknown AEHLERT
Published by Elsevier Health Sciences, United Kingdom (2013)
ISBN 10: 0080983502 ISBN 13: 9780080983509
New Hardcover Quantity Available: 1
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description Elsevier Health Sciences, United Kingdom, 2013. Hardback. Condition: New. 2nd edition. Language: English. Brand new Book. Specification of Drug Substances and Products: Development and Validation of Analytical Methods is a comprehensive and critical analysis of the requirements and approaches to setting specifications for new pharmaceutical products, with an emphasis on phase-appropriate development and validation of analytical methods. This book is intended as more than a review of new regional guidelines, existing regulatory guidance, and industry practices. It provides a hands-on guide to understanding and applying these in practice. The authors discuss critical issues, novel approaches, and future directions while also providing insight into how International Guidelines were developed and the rationale behind them. Seller Inventory # AAU9780080983509

More information about this seller | Contact this seller

Buy New
US$ 97.68
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

4.

Unknown AEHLERT
Published by Elsevier Health Sciences, United Kingdom (2013)
ISBN 10: 0080983502 ISBN 13: 9780080983509
New Hardcover Quantity Available: 1
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Elsevier Health Sciences, United Kingdom, 2013. Hardback. Condition: New. 2nd edition. Language: English. Brand new Book. Specification of Drug Substances and Products: Development and Validation of Analytical Methods is a comprehensive and critical analysis of the requirements and approaches to setting specifications for new pharmaceutical products, with an emphasis on phase-appropriate development and validation of analytical methods. This book is intended as more than a review of new regional guidelines, existing regulatory guidance, and industry practices. It provides a hands-on guide to understanding and applying these in practice. The authors discuss critical issues, novel approaches, and future directions while also providing insight into how International Guidelines were developed and the rationale behind them. Seller Inventory # AAU9780080983509

More information about this seller | Contact this seller

Buy New
US$ 100.08
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

5.

Riley
ISBN 10: 0080983502 ISBN 13: 9780080983509
New Quantity Available: 2
Seller:
Romtrade Corp.
(STERLING HEIGHTS, MI, U.S.A.)
Rating
[?]

Book Description Condition: New. Brand New Original US Edition.We Ship to PO BOX Address also. EXPEDITED shipping option also available for faster delivery.This item may ship fro the US or other locations in India depending on your location and availability. Seller Inventory # AUNEW-31435

More information about this seller | Contact this seller

Buy New
US$ 101.06
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds

6.

Christopher M Riley (editor), Thomas W Rosanske (editor), Shelley R. Rabel Riley (editor)
Published by Elsevier Science 2013-09-17, Amsterdam (2013)
ISBN 10: 0080983502 ISBN 13: 9780080983509
New Hardcover Quantity Available: 1
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Elsevier Science 2013-09-17, Amsterdam, 2013. hardback. Condition: New. Seller Inventory # 9780080983509

More information about this seller | Contact this seller

Buy New
US$ 99.75
Convert currency

Add to Basket

Shipping: US$ 6.50
From United Kingdom to U.S.A.
Destination, rates & speeds

7.

Christopher M. Riley, Thomas W. Rosanske, Shelley R. Rabel Riley,
ISBN 10: 0080983502 ISBN 13: 9780080983509
New Hardcover Quantity Available: 3
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Hardback. Condition: New. Not Signed; Specification of Drug Substances and Products: Development and Validation of Analytical Methods is a comprehensive and critical analysis of the requirements and approaches to setting specifications for new pharmaceutical products, with an emphasis on phase-appropriate development and validation of a. book. Seller Inventory # ria9780080983509_rkm

More information about this seller | Contact this seller

Buy New
US$ 104.55
Convert currency

Add to Basket

Shipping: US$ 5.13
From United Kingdom to U.S.A.
Destination, rates & speeds

8.

Published by Elsevier Health Sciences
ISBN 10: 0080983502 ISBN 13: 9780080983509
New Hardcover Quantity Available: 3
Seller:
THE SAINT BOOKSTORE
(Southport, United Kingdom)
Rating
[?]

Book Description Elsevier Health Sciences. Hardback. Condition: New. New copy - Usually dispatched within 2 working days. Seller Inventory # B9780080983509

More information about this seller | Contact this seller

Buy New
US$ 102.15
Convert currency

Add to Basket

Shipping: US$ 9.21
From United Kingdom to U.S.A.
Destination, rates & speeds

9.

Aehlert, Unknown
ISBN 10: 0080983502 ISBN 13: 9780080983509
New Quantity Available: 3
Seller:
Paperbackshop-US
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description 2013. HRD. Condition: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Seller Inventory # BB-9780080983509

More information about this seller | Contact this seller

Buy New
US$ 111.33
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

10.

Shelley R. Rabel Riley Thomas W. Rosanske Christopher M. Riley
Published by Elsevier
ISBN 10: 0080983502 ISBN 13: 9780080983509
New Quantity Available: 4
Seller:
Books Puddle
(New York, NY, U.S.A.)
Rating
[?]

Book Description Elsevier. Condition: New. pp. 390. Seller Inventory # 2697815928

More information about this seller | Contact this seller

Buy New
US$ 114.25
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

There are more copies of this book

View all search results for this book